EUVIMEDEUVIMED entdecken
Crossref

Engineered yeast: a breakthrough in targeted cancer therapies

Gautam Dantas

The Biomedical & Life Sciences Collection · 31.03.2026 · 2026 (3) · e1008373

DOI: 10.69645/zacw4207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Biomedical & Life Sciences Collection, online erschienen am 31.03.2026. Verfasst von Gautam Dantas.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dantas, G. (2026). Engineered yeast: a breakthrough in targeted cancer therapies. The Biomedical & Life Sciences Collection, 2026(3), e1008373. https://doi.org/10.69645/zacw4207

Vancouver

Dantas G. Engineered yeast: a breakthrough in targeted cancer therapies. The Biomedical & Life Sciences Collection. 2026;2026(3):e1008373. doi:10.69645/zacw4207

BibTeX
@article{Dantas2026,
  author = {Dantas, Gautam},
  title = {Engineered yeast: a breakthrough in targeted cancer therapies},
  journal = {The Biomedical & Life Sciences Collection},
  year = {2026},
  volume = {2026},
  number = {3},
  pages = {e1008373},
  doi = {10.69645/zacw4207}
}
Kostenlos starten →